SEC Delays Decision on Several Ethereum ETFs; Injective & InQubeta Aim for 100%+ Gains

The US Securities and Exchange Commission (SEC) has been in the news for delaying the spot Ethereum (ETH) Exchange-Traded Funds (ETFs) of multiple companies. The Grayscale Ethereum Futures ETF joined Coinbase Global and Hashdex whose applications were either delayed or denied by the US regulatory body.

Amidst the disappointment, the only silver lining was the strong growth of InQubeta (QUBE) and Injective (INJ) which analysts suggest can potentially rise by 100%. InQubeta is the newest of the two top crypto coins and has shown a robust trajectory. It’s powered by Ethereum and connects AI startups with investors.

The platform has been in the limelight because of its steady prospects and unique model. Its presale funding has also been much admired. It currently stands at $7.5 million.

InQubeta: Powering Startups’ Growth

InQubeta is a decentralized solution that makes fundraising accessible for AI startups. The platform combines blockchain technology with market dynamics to create a transparent investment mechanism for its users. It allows startups to get financing for AI projects, and investors get to back future-ready initiatives.

To ensure that these investment deals are executed seamlessly, the platform has a native cryptocurrency called the QUBE token. The token is built using the ERC-20 standard and can be bought on presale.

With a supply of 1.5 billion, the QUBE token has been designed to support InQubeta’s development in multiple ways. Not only is it used for settling payments, but it is also used for deciding which changes are suitable for the protocol thanks to its role as a governance token.

If a community member suggests a protocol change, their proposal is vetted and then put to a vote before token holders, who have exclusive voting privileges. A voter can use their discretion to decide if the change is needed or not.

The QUBE token can also be staked to earn additional passive income. The staked assets aid the platform’s development by injecting liquidity. Their owners are rewarded for their patience with crypto rewards. To reward stakers, InQubeta maintains a rewards pool and funds it via tax collections.

QUBE is among the best crypto investments that you will find in the market today as it keeps returns safe from inflation and market volatility. This is achieved by controlling the token supply and keeping it scarce.

When the supply is limited, there are minimal price fluctuations which drives the asset value. If the supply does rise, it’s reduced again by burning the excess tokens.

The number of active addresses rises to 250,000 on Injective

Injective is a good crypto to buy if you are looking for diverse DeFi applications. It has been designed as a Layer 1 blockchain that offers cutting-edge Web 3.0 applications. The protocol can be used to create powerful dApps with CosmWasm. The smart contracts layer can add speed and scalability to the dApps.

Another reason why developers prefer working with Injective is because they can create customized DeFi applications. Using plug-and-play modules and deep liquidity support, they can create a range of dApps. Its native token is INJ and it is used for all transactional purposes within the blockchain.

Injective recently achieved a new milestone after the active addresses on its network rose significantly. The team announced that on December 22, 2023, the number of active addresses on the blockchain reached 250,000.

Ethereum plans January launch for testnet DenCun

Ethereum is among the most widely used blockchains in the world because of its high-end performance and scalability. Its flagship technology is used for deploying dApps, crypto tokens, NFTs, and other decentralized solutions. The proof-of-stake blockchain’s native token is known as ETH.

In a recent development, Ethereum developers said they plan to roll out the testnet of Cancun-Deneb (DenCun), which is the blockchain’s next update.

Between January and February, three testnets will be implementing the upgrade –  Goerli (January 17), Sepolia (January 30), and Holesky (February 7).

According to reports, DenCun is expected to lower gas fees and boost Ethereum’s data storage  capacity. Proto-danksharding is among the new features included in the upgrade.

Conclusion

Ethereum, Injective, and InQubeta are the best altcoins to buy now as they can secure your present and future. While crypto users prefer them for their impressive growth, analysts are also backing these tokens for their long-term growth potential.

The three cryptocurrencies are known for their strong security framework and features that ensure a holistic user experience.

Visit InQubeta Presale

Exit mobile version